Pharmacotherapy of diarrheal diseases: an approach based on physiologic principles.
D000284:Administration, Oral; D000893:Anti-Inflammatory Agents / Q000627:therapeutic use; D001599:Berberine / Q000627:therapeutic use; D002121:Calcium Channel Blockers / Q000627:therapeutic use; D002147:Calmodulin / Q000037:antagonists & inhibitors; D002712:Chlorides / Q000378:metabolism; D002738:Chloroquine / Q000627:therapeutic use; D003620:Dantrolene / Q000627:therapeutic use; D003967:Diarrhea / Q000188:drug therapy* / Q000503:physiopathology; D005938:Glucocorticoids / Q000627:therapeutic use; D006801:Humans; D007408:Intestinal Absorption / Q000187:drug effects; D008094:Lithium / Q000627:therapeutic use; D009294:Narcotics / Q000627:therapeutic use; D009525:Niacin / Q000627:therapeutic use; D012964:Sodium / Q000378:metabolism; D013004:Somatostatin / Q000627:therapeutic use; D013566:Sympathomimetics / Q000627:therapeutic use
D000893:Anti-Inflammatory Agents; D002121:Calcium Channel Blockers; D002147:Calmodulin; D002712:Chlorides; D005938:Glucocorticoids; D009294:Narcotics; D013566:Sympathomimetics; D001599:Berberine; D009525:Niacin; D013004:Somatostatin; D002738:Chloroquine; D008094:Lithium; D012964:Sodium; D003620:Dantrolene